AzTrials
AzTrials

Food Allergy in ChildrenNCT03495583

The EAT-On Study: Sensitisation, Allergy and Child Health

A study testing Early introduction in people with Food Allergy in Children and Obesity, Childhood, run by King's College London at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The EAT Study showed a reduction in both sensitisation (to all foods) and clinical food allergy (to peanut and egg) among children who consumed allergenic food early compared with those who followed standard government feeding advice to exclusively consume breast milk for the first 6 months of life. Read more about this study

Who is it for?
Ages 7 to 8 years
What is being tested?
Early introduction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,235 participants
Where
1 siteUnited Kingdom
Study dates
3 Apr 2018to Apr 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 8 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Previous participation in the EAT study
  • Age 8 years +/- 12 months

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Paediatric Allergy

    London

Other trials in United Kingdom

About this study

Official title: Effects of Early Introduction of Allergenic Foods Followed by Ad-libitum Consumption, on Food Allergic Sensitisation, Allergy and Measures of Child Health at 8 Years of Age in Exclusively Breastfed Infants

The EAT Study showed a reduction in both sensitisation (to all foods) and clinical food allergy (to peanut and egg) among children who consumed allergenic food early compared with those who followed standard government feeding advice to exclusively consume breast milk for the first 6 months of life. The EAT-On Study aims to establish whether the effects seen at 3 years in the EAT study represent a delay in FA onset or sustained tolerance. EAT-On will also investigate the natural history (emergence and resolution) of FA in childhood; thus shaping dietary and management plans for allergic patients. Findings will inform future research and weaning recommendations for preventing FA.

Read the detailed description

Sensitisation/Allergy:

Food allergy (FA) is common, increasing in prevalence and represents a public health concern in many countries. FA increasingly affects geographic regions where rates of FA were previously low.(1-5) Data from the Enquiring About Tolerance (EAT) study, which enrolled 1303 exclusively breastfed three month old babies from the general population, showed that 8% of children had proven immediate-onset FA at three years of age. This equates to almost 1 in 10 children. (1) The early-introduction of specific food allergen(s) to infant diets is a successful strategy for the prevention of FA. Introduction of peanut to the infant diet before 11 months of age, protected against the development of peanut allergy in a high-risk, atopic population.(6) This effect persisted despite cessation of peanut consumption for 12 months.(7) In the EAT Study, children from the general population were randomised either to consume six commonly allergenic foods (cow's milk, egg, peanut, wheat, fish and sesame) from four months of age (early introduction group (EIG)), or to follow Department of Health (DoH) advice to exclusively breastfeed until about 6 months of age (standard introduction group (SIG)). The per-protocol analysis revealed a reduction in any FA of 7.3% versus 2.4% (p=0.01), for peanut allergy of 2.5% versus 0% (p=0.003) and for egg allergy 5.5% versus 1.4% (p=0.009) in the SIG and EIG respectively. (8) In the EAT study, between 1 and 3 years an intention-to-treat analysis (ITT) of sensitisation to individual foods showed a significant cumulative treatment effect of 35% (p=0.0095) in the EIG (unpublished data). Furthermore, in the per-protocol analyses (PP), we showed a statistically significant reduction of 41.6% (p=0.01) in skin prick test (SPT) sensitivity to any food at 1 year, and again at 3 years with a 67.3% relative reduction (RR) (p=0.002) in the EIG. These findings were particularly significant for individual food; at 3 years there was a relative reduction in skin-prick sensitivity to all individual foods and particularly for peanut (RR 67.1% p=0.007).

FA is a dynamic condition with egg and milk allergy typically developing in infancy and being outgrown and peanut and sesame allergy usually developing between the ages of 3-6 and persisting into adulthood. Whilst early introduction of commonly allergenic foods is effective in preventing food allergy in early childhood and within the confines of a randomised controlled trial (RCT), the longevity of this novel approach has not been tested and little is known about whether these effects are sustained after 'real world' ad libitum consumption. The EAT-On Study aims to investigate this by following-up children who were previously enrolled in the EAT Study when they are 8 years of age and investigating the natural history of food allergy, and how the intervention that was applied when children were 4-6 months of age influences food allergic sensitisation and clinical food allergy when they are 8 years of age.

Child Health:

Whilst the UK Department of Health recommends exclusive breastfeeding (EBF) until around six months of age, surveys suggest this is achieved by only 1% of mothers(9). Given the lack of EBF till 6 months of age, the majority of infants will require additional nutrition provided from formula and/or solid weaning foods. Indeed, 75% of infants have been introduced to solid food by 5 months of age (9). The nutritional consequences of different weaning regimens may have important consequences on obesity outcomes, but rigorous trials in this area are difficult to undertake, not least because of the necessary ethical concerns that pertain to the comparison of breast-feeding with alternate or complementary feeding strategies. The EAT cohort presents a unique opportunity to study this question further as the diet consumed by children who participated in the EIG of the EAT study is much higher in protein than breastmilk alone. Good quality studies have found that consumption of high protein formula milk in early infancy increases the risk of overweight in later childhood compared with breastfeeding, but the effect of high protein solid food consumption alongside breastfeeding in early infancy has not been studied. The majority of infants have solid food introduced before 6 months of age, and updated guidance advocates the introduction of a high protein food (peanut) from 'around 6 months of age' (UK(10) and Australia(11)), or at 4 months of age (USA(12)) to prevent a new onset of peanut allergy. It is therefore timely to explore how early diet, particularly with respect to high protein weaning diet, influences childhood obesity. This will lead to the development of clearer guidance in respect to early weaning diet which extends to other high protein foods, while taking in to account the risk of childhood obesity.

The nature of the EAT cohort means that between 4 and 6 months of age children were randomised either to a lower protein diet (SIG) or to a higher protein diet (EIG): breastmilk contains approximately 6% energy from protein whilst the EIG were asked to consume a diet containing at least 15% energy from protein, more than double that of the SIG. This cohort therefore offers a unique opportunity to explore the effect of differing energy consumption from dietary protein on overweight/obesity and markers of cardiovascular health in later childhood.

Being tested
Early introduction
Keywords
Food allergy, Child Health, Oral tolerance induction, Food allergic sensitisation, Obesity
Medical subject headings
Pediatric Obesity, Food Hypersensitivity, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early introductionOther

    Consumption of 2g/week of cow's milk, hen's egg, wheat, peanut, sesame and fish protein from 3 months of age (alongside breastfeeding)

Study groups in NCT03495583
Study groupRoleWhat they receive
Early introductionExperimentalSix commonly allergenic foods introduced (in a randomly assigned order) into the diets of exclusively breastfed infants from about 3 months of age.
Receives: Other: Early introduction
Standard introductionNo interventionInfants followed UK DoH standard advice for weaning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Allergic sensitisation

    Between group differences in total number of cumulative sensitisations to the six study food allergens at age 8

    Measured: 3 years

  2. Food allergy

    Between group differences in cumulative food allergy (challenge confirmed) t the six study foods at age 8

    Measured: 3 years

  3. Child Health

    Between group differences in proportion of children who classified as overweight or obese as determined by their BMI and/or BMI z score

    Measured: 3 years

Secondary outcomes (25)
  1. Other allergic sensitisations

    Between group differences in proportion of children with SPT sensitisation to additional food allergens (hazelnut, brazil nut, cashew, almond and walnut) and aero-allergens (timothy grass, birch pollen, house dust mite, cat and dog dander).

    Measured: 3 years

  2. Mechanisms of allergy

    Between group differences in specific IgE, IgG and IgG4 to peanut, egg, sesame and aeroallergens

    Measured: 3 years

  3. Coeliac disease

    Between group differences in prevalence of coeliac disease using coeliac antibody test (tTG IgA) screening test

    Measured: 3 years

  4. Atopic dermatitis

    Between group differences in prevalence of atopic dematitis

    Measured: 3 years

  5. Allergic rhinoconjunctivitis

    Between group differences in prevalence of seasonal and perennial rhinoconjunctivitis

    Measured: 3 years

  6. Asthma

    Between group differences in prevalence of asthma

    Measured: 3 years

  7. Oral allergy syndrome

    Between group differences in prevalence of oral allergy syndrome

    Measured: 3 years

  8. Parent reported food allergy

    Between group differences in food reaction history (parent-reported immediate onset food allergy)

    Measured: 3 years

  9. Sibling allergies

    Prevalence of sibling allergies (food allergies, eczema, asthma and rhinitis)

    Measured: 3 years

  10. AGE Level in association with food allergies

    Between group differences in AGE levels in association with food allergies

    Measured: 3 years

  11. Skin fold thickness

    Between group differences in skin fold thickness (triceps and subscapular)

    Measured: 3 years

  12. Circumference measurements

    Between group differences in midarm, waist and head circumference

    Measured: 3 years

  13. Anthropometric ratios

    Between group differences in; adjusted weight for height; waist; height ratio; height adjusted weight circumference

    Measured: 3 years

  14. Fat free mass

    Between group differences in fat free mass

    Measured: 3 years

  15. Conicity index

    Between group differences in conicity index (calculated from waist circumference and height and weight measurements)

    Measured: 3 years

  16. Cardiovascular health

    Between group differences in the proportion of children with cardiovascular measurements outside the expected range

    Measured: 3 years

  17. Vascular stiffness

    Between group differences in vascular stiffness

    Measured: 3 years

  18. AGE

    Between group differences in advanced glycation end products (AGE)

    Measured: 3 years

  19. Inflammation

    Between group differences in inflammation (measured using IL=6; sensitive CRP; TNF alpha; MCP-1; RANTES chemokine

    Measured: 3 years

  20. Metabolic and endocrine

    Between group differences in insulin, IGF-1 and leptin

    Measured: 3 years

  21. White cell count

    Between group differences in total white blood cell count

    Measured: 3 years

  22. Macronutrient dietary intake

    Between group differences in macronutrient intake

    Measured: 3 years

  23. Dietary habits

    Between group differences in fussy eating

    Measured: 3 years

  24. Physical activity

    Influence of physical activity on anthropometry and body composition measurements

    Measured: 3 years

  25. Genetic influences

    Influence of parental size on: height; weight; waist circumference on participant's size

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Apr 2018
  2. Study start3 Apr 2018
  3. Primary completionApr 2021 (estimated)
  4. Study completionApr 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomised controlled trial in which breastfed infants were randomised (equal groups) either to introduce 6 allergenic foods (cow's milk, egg, wheat, peanut, sesame, fish) from 3 months of age or to continue exclusive breastfeeding until about 6 months of age.
Masking
None (open label)
Enrolment
1,235 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03495583
Sponsor's protocol ID
GN2551
Status last verified
Mar 2018
First submitted
4 Apr 2018
Last updated
12 Apr 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Early introduction in people with Food Allergy in Children and Obesity, Childhood, run by King's College London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Allergic sensitisation (time frame: 3 years). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in